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Adult animals of different species can be made unresponsive to various anti- 
gens by passive immunization or exposure to small amounts of antigen. Anti- 
body, either passively administered or actively produced in small quantities, 
may  provide a homeostatic or "feedback" mechanism which limits production of 
specific  antibody to that portion of the antibody-forming system previously 
stimulated by  the  antigen  (1).  The  present  studies  suggest  that  an  active 
immune response  resulting in  low  levels  of antibody formation is  partially 
responsible for maintaining tolerance produced by neonatal injections of anti- 
gen. 
Very low doses of sheep erythrocytes induced increased numbers of plaque- 
forming or antibody-releasing cells in the absence of detectable circulating anti- 
body (1). This suggested that the plaque-forming cell response might be useful 
for detecting an active immune response in rats made tolerant to sheep eryth- 
rocytes by intraperitoneal injections of large doses of the antigen beginning at 
birth (2, 3). 
In this paper,  the plaque-forming cell and antibody response will be char- 
acterized for rats of varying age which received a  single antigen injection of 
sheep  erythrocytes.  The  antigen  dose  was  sufficient to  induce  tolerance  if 
repeated injections were begun at birth. The plaque-forming cell and antibody 
response were also studied in rats receiving repeated injections of this dose of 
antigen beginning during adult life. In the following paper the plaque-formlng 
cell and antibody response will be  characterized for rats  that have received 
repeated antigen injections beginning at birth. It will be shown that the im- 
munological response is quantitatively, but apparently not qualitatively, dif- 
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ferent in rats receiving repeated antigen injections as adults compared with rats 
receiving antigen injections beginning at birth. 
Materials and Methods 
Sprague-Dawley male and female rats were used. Litters were separated according to sex 
at 4 weeks of age. Experimental groups were made up of animals of the same age either male 
or female, or of equal numbers of males and females. Since the immunological responses of 
males and females were similar within an experiment, the sex of the animals is not reported. 
Antigens and Antibody Titers.--The antigen was 0.2 ml of a  20 per cent suspension (ap- 
proximately 8  X  l0  s  cells)  of washed whole sheep erythrocytes injected intraperitoneally. 
Rats 3 weeks old and less were not anesthetized for injections; the needle was inserted into 
the peritoneal cavity through the head of the femur to diminish leak of antigen through the 
needle track. In older animals, the antigen was injected directly into the peritoneal cavity 
during anesthesia. Repeated injections of antigen were always given twice a week at regularly 
alternating 3- and 4-day intervals. 
Blood for antibody titers was obtained from the lateral tail vein or by heart puncture when 
animals were sacrificed. Sera were stored at -30°C and were titrated together at the comple- 
tion of each experiment. All sera were inactivated at 56°C for 30 minutes. Antibody titrations 
used the double dilution technique with an initial serum dilution of 1:10.  Serum dilutions 
higher than 1:10 were made in saline containing 1 per cent inactivated normal rat serum. 
Two-tenths ml of a  0.25 per cent suspension of sheep erythrocytes was added to 0.3 ml of 
each serum dilution. The tubes were shaken briefly and incubated at room temperature over- 
night. High concentrations of antibody produced  an evenly dispersed film of erythrocytes 
covering the bottom of the tubes, sometimes with crinkling at the margins of the film. This 
pattern of hemagglutination was considered a 4+ reaction. Lower concentrations of antibody 
produced pale rings of dispersed erythrocytes which could be ranked as 3+ to 1+ reactions; 
these reactions could be clearly differentiated from the central dense circumscribed sedimenta- 
tion of erythrocytes found with normal serum or with very high dilutions of antisera. Anti- 
body titers were designated for convenience as  "total" for tmtreated sera and as  "7S" for 
antibody activity remaining after treatment of  sera with 2-mercaptoethanol (2-ME).  The 
titration for 7S antibody was identical to that for total antibody, except that serum diluted 
1:5 in saline was added to an equal volume of 0.1 M 2-ME, incubated at 37°C for 30 minutes 
and titrated as described above. Titers were recorded as the number of the last tube showing 
1+ hemagglutination; thus, the titer expressed the serum dilution of 10 X  2 n where n  is the 
tube number. Mean titers for groups of rats 4- the standard error of the mean are reported in 
Tables I  and II. A titer of 0 was arbitrarily assigned to sera producing no hemagglutination 
at serum dilution of 1:10.1 
Plaque-Forming Cells.--The methods of Jerne and Nordin for demonstrating release of 
antibody by single cells in agar plates was used with minor modifications (1). Each spleen 
from an adult immunized rat was minced and passed through a No. 80 tantalum gauze screen 
1 Hemolysin titers using complete hemolysis as an end point were reported in a  previous 
publication (1). Many sera containing predominantly 19S or a  mixture of  19S and 7S anti- 
bodies have been titrated by both the hemolysin and agglutinin techniques.  Using a  4+ 
end point, sera untreated with 2-ME had the same hemolysin or hemagglutinin titers plus or 
minus one tube. The presence of 2-ME in low serum dilutions was antieomplementary but 
did not measurably effect titration of low concentrations of 7S antibody using the hemag- 
glutination technique. In experiments described in the succeeding paper, the titration of low 
concentrations of total and 7S antibody was important; and it, therefore, seemed desirable 
to consider 1+ hemagglutination as an appropriate end point. DONALD  A. ROWLE¥  AND  FRANK  W. FITCH  673 
using a pestle and 4.0 ml of the tissue culture medium  (1). The volume was brought to 5.0 
ml and tissue fragments and large aggregates of cells were removed by low speed centrifugation 
for 30 seconds. The number of nucleated cells in the suspension was determined with a hemo- 
cytometer. About 5 X  l0  s nucleated cells were recovered from spleens of adult rats. Plates 
were prepared in duplicate from 2 or more serial 1:5 or 1:10 dilutions of the suspension. 
One-tenth mi of cell suspension was used for each plate. Spleen cells from animals less than 4 
weeks of age or from non-immunized  adults were suspended in a total volume of 2.5 ml of the 
tissue culture medium.  One-tenth ml of the whole suspension and of appropriate dilutions 
were plated in duplicate for the young animals; 0.2 ml of the whole suspension was plated in 
triplicate for the non-immunized animals. The total number of plaque-forming cells per spleen 
or per 10  e recovered spleen cells was calculated from the average plaque count of at least 2 
plates prepared for each animal. Additional controls and refinements  for counting plaques 
from non-immunized rats will be described in the following paper. 
The number of nucleated cells recovered from spleens was remarkably constant, differences 
in number among individual animals similarly treated being rarely more than twofold. More- 
over, the average number of recovered spleen ceils for groups of non-lmmunized  rats or rats 
which had received 1 or multiple injections differed by no more than 10 per cent. Furthermore, 
differences in recovery of cells for these 3 groups were not consistent.  The essential results of 
the present experiments were almost identical whether the number of plaque-forming  cells 
was expressed per total spleen or per number of recovered cells. Since the data presented in 
the following paper were best expressed as numbers of plaque-forming  cells per total spleen, 
the data in this paper have been expressed in thesame way for consistency. 
EXPER  ~NTAL  OBSERVATIONS 
The Plaque-Forming  Cell and Antibody Response to a Single Antigen Injection. 
--In  a  series of experiments, rats of various ages received a  single injection of 
antigen; and groups of 3  or more animals were sacrificed 3, 4,  5  or 6,  14,  and 
21  days later. The plaque-forming cell response at 4  days was higher than at 
3 days and usually higher than at 5 or 6 days. The plaque-forming cell response 
was  invariably higher at  4  days  than  at  14  or 21  days after immunization, 
regardless of the age at which the animals were immunized.  7S antibody was 
not present until 5  or 6  days after immunization of rats 21  days or older at 
sacrifice, when it appeared in low titer. 
The  plaque-forming  cell response  at  4  days was  of particular  interest.  In 
experiments to be reported in detail, rats received repeated injections of antigen 
given at  alternating 3- and 4-day intervals.  The maximum interval between 
injections was 4  days and the peak or near peak plaque-forming cell response 
occurred 4  days after immunization.  In a  series of experiments, 66 rats were 
sacrificed 4 days after a single antigen injection; the number of plaque-forming 
cells per spleen of each animal is plotted according to age at sacrifice in Fig. 1. 
The  number  of plaque-forming cells per spleen of 56  non-immunized rats  of 
various ages is also shown. 
Rats sacrificed at 4 or 11 days of age had no appreciable plaque-forming cell 
response and no measurable circulating antibody. Rats immunized at age  17 
days and sacrificed at 21 days had an unequivocal response: spleens contained 
5000 to 29,000 (mean 14,000) plaque-forming cells and antibody titers were 7 or 674  TOLERANCE  IN RATS TO SHEEP ERYTHROCYTES. I 
8 (mean 7). The mean titer for this group was as high or higher than the mean 
titers for groups of older rats. Forty-six rats were 49 days or older at sacrifice; 
these animals had 23,000  to 950,000  (mean 218,000)  plaque-forming cells in 
their spleens and antibody titers ranging from 4 to 10 (mean 7). The rats 49 
days or older weighed 190 to 340 gm and the plaque-forming cell and antibody 
response had no apparent correlation with body weight. The 21-day-old rats 
weighed 66 to 85 gm. The high antibody titers of these younger animals in the 
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FIG. 1.  The plaque-forming  cell response of rats of various ages. The response was meas- 
ured 4  days after a  single antigen injection. 
presence of fewer plaque-forming cells presumably was due to the higher ratio 
of plaque-forming cells to body weight and blood volume. 
The plaque-forming cell  response of older rats varied from experiment to 
experiment, no consistent effect being attributable to age. Variations in plaque- 
forming cell response were usually as great between rats sacrificed at the same 
time  as  between  rats  sacrificed at  different times.  The  plaque-forming cell 
response  correlated,  with considerable  overlap,  with antibody titers;  Fig.  2 
illustrates this correlation in 27 adult rats. 
Most non-immunized rats had 80 to 100 plaque-forming cells in their spleens, 
and there was no apparent change in the number of their plaque-forming cells DONALD  A.  ROWLEY  AND  FRANK  W.  I~ITCH  675 
with age.  Similar numbers  of plaque-forming cells  have also been found in 
spleens of non-immunized adult mice (4). 
Tke Plaque-Forming Cell and Antibody  Response to Multiple  Injections  of 
Antigen.--The plaque-forming cell and antibody response of adult rats receiving 
3 or more antigen injections were measured in a series of experiments. 
In 6 experiments, 28 adult rats received multiple antigen injections; 4 rats 
received 3 injections, 20 rats received 5 injections, and 4 rats received 7 injec- 
tions of antigen. In each experiment, the plaque-forming cell and antibody 
responses of 4 to 6 rats which had received multiple antigen injections were com- 
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FIG. 2. Plaque-forming  cell and antibody response 4 days after a single antigen injection 
or after S antigen injections. Repeated antigen injections  were given twice a week. 
a single antigen injection. The rats were sacrificed 4 days after the last injection 
of antigen. Animals receiving a  single antigen injection had comparable re- 
sponses for the 6 experiments and the results for all of the animaJs have been 
combined for presentation in Table I. The relationship between the numbers of 
plaque-forming cells and antibody titers for the individual control rats and for 
rats  that  received  5  injections of antigen is  illustrated in  Fig.  2.  Animals 
receiving  repeated  injections  of antigen had  from ~,~  to  1/~  the  number  of 
plaque-forming cells  per  spleen  as  rats  receiving a  single antigen injection, 
although their total antibody titer rose. This rise was due to an increase in 7S 
antibody from a mean titer of 0 after a single injection to a mean titer of 6 after 
5  or  7  injections.  In  another experiment,  rats  were  sacrificed 4  days after 
receiving 9 antigen injections. The numbers of plaque-forming cells  and the 
antibody titers of these animals were comparable to those in rats receiving 5 or 
7 antigen injections (Table I). 
The response of these repeatedly injected animals was measured 4 days after 676  TOLERANCE  IN  RATS  TO  SHEEP  ERYTHROCYTES.  I 
the last injection of antigen. Since injections of antigen were given every 3 or 
4 days, apparently these animals had relatively constant numbers of plaque- 
forming cells and levels of circulating 19S and 7S antibody at the time of each 
subsequent  injection of antigen.  The following  experiment was  designed  to 
determine whether this  "steady state" of plaque-forming cells and antibody 
titer was altered by increasing the interval between the 4th and 5th antigen 
injections. 
The  Recovery of the Plaque-Forming Cell Response in  Animals  Receiving 
Multiple Antigen [njections.--In  the  previous  experiments,  rats  which  had 
received 5 injections of antigen had considerably fewer plaque-forming cells in 
TABLE I 
Plaque-Forming Cell and Antibody Response to Single or Multiple  Antigen Injections 
Plaque-forming 




No. of antigen injections 
1  3  5  7 
(27 rats)  (4 rats)  (20  rats)  (4 rats) 
151,000 4- 32,00034,000 ±  11,20018,100 4- 3300 
6.3  4- 0.27 
0 
7.0 4- 0.70 
2.2  4-  1.30 
7.5  4- 0.29 
6.2  4-  0.38 
20,000 4-  5000 
7.5  4- 0.30 
6.25  4- 0.25 
* Animals sacrificed 4 days after the last antigen injection. Results are expressed as the 
mean -4- the standard error of the mean. 
their spleens than animals which had received a  single antigen injection. The 
interval between the 4th and 5th injections was 3 days and the response was 
measured 4 days after the 5th antigen injection. In the following experiments, 
the interval between the 4th and 5th injections was varied and the response was 
again measured 4 days after the 5th antigen injection. 
Three groups of 6 animals received 4 injections of antigen. The interval be- 
tween the 4th and 5th injections was 3 days for I group, and 10 and 17 days for 
the other 2 groups. The schedule of injections was arranged so that all 3 groups 
received the 5th antigen injection on the same day. All animals were bled for 
antibody titers on the day before the 5th antigen injection. A 4th group of 6 
rats  received a  single  antigen  injection on  the  same  day  as  the  other rats 
received the 5th antigen injection. All 24 rats were sacrificed on the same day, 
4 days after the final antigen injection. The experiment was repeated with in- 
tervals of 3 and 32 days between the 4th and 5th injections in 2 groups, while a 
3rd group received only a single antigen injection. The responses of the similarly 
treated groups in the 2 experiments were comparable and the data from both 
experiments have been combined for presentation in Table II. DONALD  A.  ROW-LEY  AND  FRANK  W.  FITCH  677 
As in  the previous experiments,  the rats  receiving 5 antigen  injections at 
alternating 3- and 4-day intervals had about ~  the number of plaque-forming 
cells in their spleens as control rats receiving a single antigen injection. These 
rats had a slightly higher  total antibody titer than rats receiving  a single anti- 
gen injection and this was accounted for by a rise in the 7S antibody titer. 
Increasing  the interval between the 4th and 5th injections to  10 days in- 
creased  the  plaque-forming  cell  response  by about  twofold;  increasing  the 
interval to 17 or 32 days increased the plaque-forming cell response by about 
TABLE  II 
Recovery of the Plague-Forming Cell and Antibody Response Following Multiple Antigen 
Injections 
Plaque-forming  cells 
per spleen~ 
Antibody  titer:~ 
Total 
7S 




Days between the last 2 antigen injections* 
3 
(12  rats) 
15,900  4-  1600 
7.5  4- 0.34 
6.25  4- 0.51 
1.3  4- 0.33 
1.6  4- 0.34 
10 
(6 rats) 
30,000 4- 3900 
8.5  4- 0.22 
7.0  4- 0.26 
1.7  4- 0.66 
1.0  4- 0.51 
17 
(6 rats) 
83,800  4-  5800 
8.3  4- 0.41 
6.3  4- 0.47 
2.3  4- 0.56 
1.8  4- 0.48 
32 
(6 rats) 
87,200  4- 4200 
10.0  4- 0.36 
8.5  4- 0.56 
2.0  4- 0.73 
1.3  4- 0.80 
Controls  1 
antigen injection 
(12 rats) 
129,000  4- 26,900 
6.2  4- 0.32 
0 
* The animals received a  total of 5 antigen injections. 
Animals sacrificed 4 days after the last antigen injection. Results are expressed as the mean 4- the standard 
error of the mean. 
The antibody tlter at sacrifice minus the antibody titer the day prior to the 5th antigen injection, 
five-to sixfold. The antibody titers remained high in rats 10 to 32 days after the 
4th antigen injection. The antibody titers rose significantly  after the 5th anti- 
gen injection when the interval between the 4th and 5th injections was 17 or 32 
days. 
In other experiments, animals were sacrificed 14 to 21 days after the last of a 
series of antigen injections. Invariably, the numbers of plaque-forming cells in 
the spleens of these animals were lower than in animals  sacrificed 4 days after 
the last injection of antigen. Therefore, the rise in plaque-forming cell response 
observed in the present experiment was due to the last antigen injection, and 
the recovery of the plaque-forming cell response occurred as a result of the in- 
creased interval between the final 2 antigen injections. 
DISCUSSION 
Only the spleen was sampled for plaque-forming cells in the present experi- 
ments.  In  other experiments,  we have measured the  plaque-forming cell re- 
sponse in lymph nodes after intravenous or intraperitoneal antigen injections. 678  TOLERANCE  IN RATS TO SIIEEP ERYTHROCYTES.  I 
Only 1/~o to 1/~00 as many plaque-forming cells per  10  ° recovered cells  were 
found in lymph nodes as in spleens of the same animals. When large numbers 
of cells from animals with high antibody titers were  added to the  agar  sheep 
erythrocyte suspension for plating, the suspensions contained sufficient serum 
antibody to lyse all or most of the sheep erythrocytes. Unwashed lymph node 
cell suspensions from animals immunized with high doses of antigen had to be 
diluted with the result that plaque-forming cell counts were very low. Alterna- 
tively, the lymph node cell suspensions had to be washed with risk of cell dam- 
age. Lysis of red cells by preformed antibody was not a problem with unwashed 
spleen cell suspensions; sufficient numbers of plaque-forming cells were present 
in dilutions which did not cause lysis of the plates but contained adequate num- 
bers of plaque-forming cells for counting. 
Although the ratio of plaque-forming cells to other cells was much higher in 
the spleen than in the lymph nodes, the total antibody formation outside the 
spleen must have been appreciable.  The decision to measure the plaque-form- 
ing cell response in the spleen alone was based partly on the technical difficulties 
discussed above. In addition, it was assumed that sampling of the spleen gave an 
adequate indication of the total response in all tissues. This assumption would 
not be valid if all or most of one type of antibody, e.g. 19S, were produced in the 
spleen and all or most of another type of antibody, e.g. 7S, were produced out- 
side the spleen. However, we have not been able to demonstrate such a separa- 
tion of production of types of antibody in intact and splenectomized rats injec- 
ted with sheep erythrocytes (5). 
Using isolated single cells in microdroplets, Nossal has shown that some cells 
produce 19S, other cells produce 7S, and a few cells produce both 19S and 7S 
antibody (6). Fluorescent immunohistochemical studies have furnished similar 
information (7, 8). It is not known presently whether one cell type synthesizes 
19S and another cell type synthesizes 7S antibody, or whether the synthesis of 
different antibody types occurs during different phases of growth or maturation 
of a single cell type. 
Increased numbers of plaque-forming cells were observed in spleens of rats 
2 and 3  days after primary immunization, and before detectable circulating 
antibody was present (5). Four days after primary immunization, only 19S anti- 
body was detectable in serum and the numbers of plaque-forming cells in spleens 
correlated reasonably well with circulating titers of 19S antibody. Undoubtedly, 
plaques were formed by cells producing 19S, or predominantly 19S, antibody. 
Purified fractions of rat anti-sheep erythrocyte 7S antibody produced hemolysis 
of sheep erythrocytes in agar plates in the presence of complement (5). There- 
fore, cells in plates releasing sufficient quantities of 7S antibody should produce 
plaques. However, it is not known whether plaques are produced by cells re- 
leasing predominantly  7S  antibody. The number of  plaque-forming  cells  in 
spleens did not correlate well with antibody titers more than 6 days after pri- DONALD  A. ROWLEY  AND  FRANK  W. FITCH  679 
mary immunization, or after repeated injections of antigen when 7S antibody was 
present in appreciable amounts of serum.  The circulating half life of passively 
administered rat antibody to sheep erythrocytes is about 1.5 days for 19S and 
about 5 to 7 days for 7S antibody. If cells produce 19S and 7S antibody at equi- 
valent rates, then about one-fifth  as many antibody-producing cells would be 
required to maintain  7S antibody titers.  Indeed, spleens  of rats receiving  re- 
peated injections of antigen contained about one-fifth as many plaque-forming 
cells as spleens  of rats receiving  1 antigen injection.  The plaque-forming cells 
of these repeatedly injected animals may represent cells producing predomi- 
nately 7S antibody, or cells recently stimulated by antigen and in the phase of 
19S antibody formation. In either case, it appears that the measurement of the 
plaque-forming cell response provides a reasonably quantitative indicator of an 
aspect of the immunological  response which may not be apparent by measure- 
ment of circulating  antibody alone. 
Antibody produced in the primary immune response appears to prevent the 
induction of new antibody-forming cells, thus providing a homeostatic mecha- 
nism limiting antibody production (1). It does not seem likely that this homeo- 
static mechanism can account for the rise in plaque-forming cell response which 
is noted when the interval between the last 2 of a series of antigen injections is 
increased.  Circulating  antibody levels  were the same at  the time of the last 
antigen injection, whether the interval between the last 2 injections was 3 or 32 
days. Nor does it seem likely that the marked decline in the number of plaque- 
forming cells produced by repeated antigen injections can be explained  by this 
homeostatic mechanism. Repeated, closely spaced antigen injections may have 
caused a decline and stabilization of numbers of plaque-forming cells because 
antigen-antibody complexes destroyed some antibody-forming cells, or the ratio 
of antibody-forming cells to antigen might have been too high or too low. How- 
ever, another explanation seems more reasonable to us. 
Although  antibody-forming  cells  are  capable  of  DNA  synthesis  and  cell 
division,  the greatest number of antibody-forming cells are found several days 
after the peak of mitotic activity (9-11). This suggests that maturation occurs 
before most cells synthesize appreciable amounts of antibody. Hence, antibody 
synthesis represents only a phase of the life cycle of antibody-forming cells. It 
seems most likely that  repeated,  closely  spaced antigen  injections interfered 
with either division or maturation  of antibody-forming cells. As the interval 
between antigen  injections  was  increased,  additional  antibody-forming  cells 
matured or were formed through cell division.  Thus,  repeated closely spaced 
antigen injections resulted in stabilization of numbers of antibody-forming cells; 
increasing  the  interval  between injections  allowed a  cumulative  increase  in 
numbers of cells capable of responding to the antigen. This mechanism, opera- 
ting together with a homeostatic mechanism by which antibody prevents induc- 
tion of new antibody-forming cells, apparently serves to regulate the extent of 680  TOLERANCE  IN RATS TO SHEEP ERYTHROCYTES. I 
the immune response to repeated antigen injections. The following paper will 
present results which indicate that these same regulatory processes  operate in 
animals made tolerant by neonatal antigen injections. 
SIYM~AR¥ 
Previous studies suggested that  an active immune response was partially 
responsible for maintaining immunological unresponsiveness to sheep erythro- 
cytes. Measurement of the plaque-forming (antibody-releasing) cell  response 
proved to be a sensitive indicator of an immune response to sheep erythrocytes 
in the absence of detectable circulating antibody to the antigen. The present 
studies were undertaken to determine whether an active immune process, meas- 
ured by the plaque4orming cell response, was partially responsible for induction 
and maintenance of tolerance. Rats injected intraperitoneally with large doses 
of sheep erythrocytes beginning at the dayof birth develop tolerance to the anti- 
gen. In this paper, the plaque-forming cell and antibody response to sheep eryth- 
rocytes was characterized for rats receiving a  single antigen injection at vari- 
ous ages and for rats which received repeated antigen injections as adults. The 
dose of antigen was the same as that used to produce tolerance; the injection 
schedule for repeated immunizations was also the same as that used to produce 
tolerance. 
Rats receiving a single antigen injection on the day of birth or at age 7 days 
had no measurable response to the antigen. Rats receiving a single antigen injec- 
tion at age 17 days and sacrificed 4 days later had an unequivocal response to 
the antigen. The spleens had about one-tenth as many plaque-forming cells as 
spleens of adult animals immunized similarly, but the antibody titers were as 
high as titers for adult animals. Presumably the high titers of these young ani- 
mals resulted from the high ratio of plaque-forming cells to body weight and 
blood volume. Adult animals receiving a single antigen injection had a peak or 
near peak plaque-forming cell response 4 days after immunization; at this time, 
sera contained high titers of 19S antibody and the numbers of plaque-forming 
cells in spleens correlated reasonably well with circulating antibody titers.  7S 
antibody appeared in serum 5 or 6 days after immunization. The numbers of 
plaque-forming cells declined progressively 2 and 3 weeks after immunization. 
Repeated twice weekly, injections of the antigen in adult rats produced a 
marked decline and then stabilization of numbers of plaque-forming cells  in 
spleens. Although the numbers of plaque-forming cells were fewer, titers of 19S 
and 7S antibody stabilized at high levels. A progressive recovery of the plaque- 
forming cell response and a  rise in antibody titer occurred when the interval 
between the last 2 injections was increased from 3 to 10, 17, or 32 days. These 
findings suggested that repeated closely spaced antigen injections interfered 
with either cell division or maturation of antibody-forming cells. As the interval 
between injections was increased,  additional antibody-forming cells  matured DONALD A,  ROWLEY AND  FRANK  W.  FITCH  681 
or were formed through cell division. Thus, relatively constant antigenic stimu- 
lation provided a  mechanism for controlling or limiting the response of anti- 
body-forming cells. 
In the following paper, it will be shown that this mechanism operating to- 
gether with a  homeostatic mechanism which prevents induction of new anti- 
body-forming cells serves to regulate the immune response to repeated injections 
of antigen. 
It is a pleasure to acknowledge  the skilled and devoted assistance of Mrs. Inger Bye Perry 
in these studies. 
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